Speaker illustration

Mr Diego Cazorla-Morallon

Hospital San Juan de Alicante, Alicante (Spain)

Stroke and myocardial infarction prevention with GLP1 analogues in high or very-high cardiovascular risk diabetic patients.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk